Sarepta Therapeutics Overview
Sarepta Therapeutics Target Price
Analysts' 12-month price predictions for SRPT.
Share Price
$36.2
Average Target Price
$110.00
203.9% upside
203.9% upside1 analysts in the last 4 months
High: $110 | Low: $110
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-21 | Piper Sandler | $110 | 203.9% upside |  |
| 2024-11-27 | Piper SandlerBiren Amin | $182 | 402.8% upside | |
| 2024-11-27 | NeedhamGil Blum | $202 | 458% upside | |
| 2024-11-07 | Robert W. BairdBrian Skorney | $193 | 433.1% upside | |
| 2024-11-07 | Cantor FitzgeraldKristen Kluska | $167 | 361.3% upside | |
| 2024-10-21 | JefferiesAndrew Tsai | $165 | 355.8% upside | |
| 2024-08-08 | Evercore ISIGavin Clark-Gartner | $179 | 394.5% upside | |
| 2024-08-08 | Piper SandlerBiren Amin | $200 | 452.5% upside | |
| 2024-08-08 | BarclaysGena Wang | $203 | 460.8% upside | |
| 2024-08-08 | RBC CapitalBrian Abrahams | $181 | 400% upside | |
| 2024-07-29 | RBC CapitalBrian Abrahams | $182 | 402.8% upside | |
| 2024-06-27 | BMO CapitalKostas Biliouris | $200 | 452.5% upside | |
| 2024-06-26 | Piper SandlerBiren Amin | $205 | 466.3% upside | |
| 2024-06-24 | Evercore ISIGavin Clark-Gartner | $185 | 411% upside | |
| 2024-06-24 | Mizuho SecuritiesUy Ear | $200 | 452.5% upside | |
| 2024-06-21 | Robert W. BairdBrian Skorney | $200 | 452.5% upside | |
| 2024-06-13 | Robert W. BairdBrian Skorney | $170 | 369.6% upside | |
| 2024-06-13 | Piper SandlerBiren Amin | $157 | 333.7% upside | |
| 2024-06-13 | BarclaysGena Wang | $185 | 411% upside | |
| 2024-06-07 | BMO CapitalKostas Biliouris | $170 | 369.6% upside | |
| 2024-05-28 | RBC CapitalBrian Abrahams | $142 | 292.3% upside | |
| 2024-05-20 | RBC CapitalBrian Abrahams | $157 | 333.7% upside | |
| 2024-05-17 | Mizuho SecuritiesUy Ear | $179 | 394.5% upside | |
| 2024-05-14 | OppenheimerHartaj Singh | $180 | 397.2% upside | |
| 2024-05-06 | Morgan StanleyMatthew Harrison | $165 | 355.8% upside | |
| 2024-05-02 | RBC CapitalBrian Abrahams | $141 | 289.5% upside | |
| 2023-03-01 | Morgan StanleyMatthew Harrison | $187 | 416.6% upside | |
| 2023-01-10 | Credit Suisse | $114 | 214.9% upside | |
| 2023-01-10 | Needham | $160 | 342% upside | |
| 2022-12-22 | BTIG | $160 | 342% upside | |
| 2022-12-16 | UBS | $158 | 336.5% upside | |
| 2022-11-03 | NeedhamGil Blum | $158 | 336.5% upside | |
| 2022-09-08 | Morgan Stanley | $135 | 272.9% upside | |
| 2022-08-15 | OppenheimerHartaj Singh | $150 | 314.4% upside | |
| 2022-08-03 | Morgan Stanley | $100 | 176.2% upside | |
| 2022-07-29 | Needham | $162 | 347.5% upside | |
| 2022-07-15 | Morgan Stanley | $80 | 121% upside | |
| 2022-05-24 | Goldman Sachs | $155 | 328.2% upside | |
| 2022-03-02 | Berenberg BankZhiqiang Shu | $94 | 159.7% upside | |
| 2022-03-02 | NeedhamGil Blum | $150 | 314.4% upside | |
| 2022-01-10 | Mizuho SecuritiesUy Ear | $160 | 342% upside | |
| 2022-01-05 | BTIGYun Zhong | $125 | 245.3% upside | |
| 2022-01-04 | OppenheimerHartaj Singh | $125 | 245.3% upside | |
| 2021-10-15 | Credit SuisseJudah Frommer | $95 | 162.4% upside | |